中国医药科学
中國醫藥科學
중국의약과학
CHINA MEDICINE AND PHARMACY
2014年
6期
107-108,111
,共3页
顾慧东%李裕昌%邱晓菊%陈普拉
顧慧東%李裕昌%邱曉菊%陳普拉
고혜동%리유창%구효국%진보랍
酪酸梭菌活菌散%手足口病%辅助治疗
酪痠梭菌活菌散%手足口病%輔助治療
락산사균활균산%수족구병%보조치료
Clostridium butyricum viable bacteria powder%Hand-foot-mouth disease%Adjuvant therapy
目的:探讨酪酸梭菌活菌散治疗手足口病的临床疗效。方法选取我院2012年6月~2013年12月收治的80例手足口病患儿为研究对象,将其按照时间的顺序平均分成A组与B组,各50例。A组患儿给予酪酸梭菌活菌散治疗,B组患儿给予常规手足口病疗法,观察两组临床治疗效果。结果 A组患儿临床治疗的起效时间、疱疹消失时间、食欲正常时间、体温恢复正常时间等均较B组短,差异均具有统计学意义(P<0.05);A组患儿临床治疗总有效率为98.0%;B组患儿总有效率为76.0%,A组患者临床效果明显优于B组,差异具有统计学意义(P<0.05);两组患儿均未发生较严重的不良反应。结论酪酸梭菌活菌散治疗手足口病的临床疗效较为显著,能在较短的时间内改善患者临床症状,值得应用推广。
目的:探討酪痠梭菌活菌散治療手足口病的臨床療效。方法選取我院2012年6月~2013年12月收治的80例手足口病患兒為研究對象,將其按照時間的順序平均分成A組與B組,各50例。A組患兒給予酪痠梭菌活菌散治療,B組患兒給予常規手足口病療法,觀察兩組臨床治療效果。結果 A組患兒臨床治療的起效時間、皰疹消失時間、食欲正常時間、體溫恢複正常時間等均較B組短,差異均具有統計學意義(P<0.05);A組患兒臨床治療總有效率為98.0%;B組患兒總有效率為76.0%,A組患者臨床效果明顯優于B組,差異具有統計學意義(P<0.05);兩組患兒均未髮生較嚴重的不良反應。結論酪痠梭菌活菌散治療手足口病的臨床療效較為顯著,能在較短的時間內改善患者臨床癥狀,值得應用推廣。
목적:탐토락산사균활균산치료수족구병적림상료효。방법선취아원2012년6월~2013년12월수치적80례수족구병환인위연구대상,장기안조시간적순서평균분성A조여B조,각50례。A조환인급여락산사균활균산치료,B조환인급여상규수족구병요법,관찰량조림상치료효과。결과 A조환인림상치료적기효시간、포진소실시간、식욕정상시간、체온회복정상시간등균교B조단,차이균구유통계학의의(P<0.05);A조환인림상치료총유효솔위98.0%;B조환인총유효솔위76.0%,A조환자림상효과명현우우B조,차이구유통계학의의(P<0.05);량조환인균미발생교엄중적불량반응。결론락산사균활균산치료수족구병적림상료효교위현저,능재교단적시간내개선환자림상증상,치득응용추엄。
Objective To observe and evaluate the clinical efficacy of Clostridium butyricum viable bacteria powder in the treatment of hand-foot-mouth disease (HFMD). Methods Eighty children with HFMD treated in our hospital from June 2012 to December 2013 were selected as the study subjects and evenly divided into group A and group B according to the time sequence,with 50 children in each group.Group A received Clostridium butyricum viable bacteria powder treatment and group B received conventional HFMD treatment.The clinical treatment effects of the two groups were observed. Results Group A was shorter than group B in the clinical treatment onset time,herpes disappearance time, normal appetite restoration time and normal body temperature restoration time, with statistically significant differences for all (P < 0.05).The total effective rate of clinical treatment of group A was 98.0% and that of group B was 76.0%;Group A had significantly better clinical effects than group B,with statistically significant difference (P < 0.05).Neither group had severe adverse reactions. Conclusion In the treatment of HFMD, Clostridium butyricum viable bacteria powder shows remarkable clinical efficacy and can improve the patients’clinical symptoms in a short time,thereby worthy of promotion and application.